• Skip to main content
  • Skip to primary sidebar
virology blog

virology blog

About viruses and viral disease

TWiV 142: Viral oinkotherapy

17 July 2011 by Vincent Racaniello

seneca valley virusHosts: Vincent Racaniello, Rich Condit, and Alan Dove

Vincent, Rich, and Alan discuss a method for identifying viruses of individual environmental bacteria, and the using a picornavirus for oncotherapy.

[powerpress url=”http://traffic.libsyn.com/twiv/TWiV142.mp3″]

Click the arrow above to play, or right-click to download TWiV 142 (69 MB .mp3, 95 minutes).

Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, by email, or listen on your mobile device with the Microbeworld app.

Links for this episode:

  • Probing individual bacteria for their viruses (Science)
  • Looking in vivo at virus-bacterium interactions (ScienceDaily)
  • Integrated fluidic circuit (Fluidigm)
  • Oncotherapy with Seneca Valley Virus (Clin Cancer Res)
  • Epidemiology of Seneca Valley virus (pdf)
  • Senecavirus at ViralZone
  • Small cell lung cancer (NCBI)
  • ECOG performance status
  • RECIST
  • TWiV on Facebook
  • Letters read on TWiV 142

Weekly Science Picks

Alan – Germlines podcast
Rich – science360
Vincent – Google+

 

Listener Pick of the Week

Angus – Science Weekly with Alok Jha

Send your virology questions and comments (email or mp3 file) to twiv@microbe.tv, or call them in to 908-312-0760. You can also post articles that you would like us to discuss at microbeworld.org and tag them with twiv.

Filed Under: This Week in Virology Tagged With: bacteria, bacteriophage, lung cancer, microfluidics, oncotherapy, picornavirus, seneca valley virus, small cell lung carcinoma, spirochete, termite, treponema, tumor, viral, virology, virus

Reader Interactions

Comments

  1. reverse phone lookup says

    17 November 2011 at 8:19 pm

    nice theme. but it takes a while to load

  2. Kurt Rote says

    11 December 2012 at 1:53 am

    Great commentary on the oncoviruses – a quick question or food for thought – why not genetically modify the virus to improve efficacy, akin to Oncovex for glioblastoma, etc.? Hopefully there is some thought in this direction if it has merit…

Primary Sidebar

by Vincent Racaniello

Earth’s virology Professor
Questions? virology@virology.ws

With David Tuller and
Gertrud U. Rey

Follow

Facebook, Twitter, YouTube, Instagram
Get updates by RSS or Email

Contents

Table of Contents
ME/CFS
Inside a BSL-4
The Wall of Polio
Microbe Art
Interviews With Virologists

Earth’s Virology Course

Virology Live
Columbia U
Virologia en Español
Virology 101
Influenza 101

Podcasts

This Week in Virology
This Week in Microbiology
This Week in Parasitism
This Week in Evolution
Immune
This Week in Neuroscience
All at MicrobeTV

Useful Resources

Lecturio Online Courses
HealthMap
Polio eradication
Promed-Mail
Small Things Considered
ViralZone
Virus Particle Explorer
The Living River
Parasites Without Borders

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.